Document is current
Any future updates will be listed below
-
Authors
Petrosellini, Chiara https://orcid.org/0000-0002-9984-710X
Eriksson, Sofia H.
Meyer, Nicholas https://orcid.org/0000-0002-7640-0284
Protti, Olivia
Bass, Nicholas
Kuchenbaecker, Karoline https://orcid.org/0000-0001-9726-603X
Siassakos, Dimitrios
McQuillin, Andrew https://orcid.org/0000-0003-1567-2240
-
Funding
Funding for this research was provided by:
Rosetrees Trust (Seedcorn2023\100148)
Rosetrees Trust (Seedcorn2023\100148)
Rosetrees Trust (Seedcorn2023\100148)
Rosetrees Trust (Seedcorn2023\100148)
Rosetrees Trust (Seedcorn2023\100148)
RCUK | Medical Research Council (G1000708)
- License Information
-
More Information
Article History
Received: 13 June 2025
Revised: 23 December 2025
Accepted: 27 January 2026
First Online: 5 February 2026
Competing interests
: NM has received speaker fees from Idorsia pharmaceuticals. SE has received honoraria for educational activities from Eisai, Fidia, Lincoln, and UCB pharma. CP, OP, KK, NB, DS and AM have no conflicts of interest to declare.
